Bavir Oral Solution 20 mg/ml & 300 mg Tablet, Solution
PDF Leaflet Revision Date: 11 April 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV in adults and children as part of antiretroviral therapy.
Dosage (summary)
Adults: 15 ml twice daily. Children (3 months to 12 years): 8 mg/kg twice daily, max 600 mg.
Onset of Action / Duration
Onset: 11 days, Duration: Not specified.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Ethanol increases AUC by 41%
- Methadone may require re-titration
Contraindications
- Hypersensitivity to abacavir
- Hereditary fructose intolerance
- Liver function impairment
- Pregnancy
- Lactation
- Infants under 3 months
Common side effects
- Hypersensitivity reactions
- Fatigue
- Nausea
- Diarrhoea
- Rash
Counselling Points
- Inform about hypersensitivity risks
- Do not restart if hypersensitivity occurs
- Monitor for symptoms of lactic acidosis
Serious warnings
- Risk of fatal hypersensitivity reactions
- Lactic acidosis
- Severe hepatomegaly
- Immune Reconstitution Inflammatory Syndrome
Important Disclaimer
The Bavir Oral Solution 20 mg/ml & 300 mg Tablet, Solution professional information leaflet below is the property of Aurobindo Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
